Herantis Pharma Oyj (HE:HRTIS) — Stock Price

€1.71 EUR
▲ 5.03% today

Herantis Pharma Oyj (HE:HRTIS) is currently trading at €1.71 EUR, up 5.03% today. Over the past 52 weeks, shares have ranged between €1.51 and €2.78. This page tracks Herantis Pharma Oyj's live share price on the HE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Herantis Pharma Oyj market cap and net worth.

Herantis Pharma Oyj (HRTIS) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Herantis Pharma Oyj's daily closing share price and trading volume on the HE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Herantis Pharma Oyj Income Statement — Revenue, Profit & Earnings by Year

Herantis Pharma Oyj's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue €0.00 €0.00 €0.00 €0.00 €0.00
Cost of Revenue €927.71K
Gross Profit €-928.00K
Research & Development €3.60 Million €2.70 Million €5.00 Million €6.20 Million €5.33 Million
SG&A €1.49 Million €1.74 Million €2.65 Million €2.25 Million €2.04 Million
Total Operating Expenses €5.03 Million €-154.00K €7.99 Million €9.05 Million €8.07 Million
Operating Income €-5.03 Million €154.37K €-7.99 Million €-9.05 Million €-8.07 Million
EBITDA €-4.93 Million €831.44K €7.98 Million €6.92 Million €-7.14 Million
EBIT €-9.96 Million €831.80K €-7.99 Million €-9.05 Million €-8.07 Million
Interest Expense €5.66K €551.60K €1.33 Million €63.03K €1.08 Million
Income Before Tax €-4.94 Million €279.84K €-9.32 Million €-23.58 Million €-9.15 Million
Income Tax Expense €-1.00 €1.33 Million €308.36K €1.08 Million
Net Income €-4.94 Million €279.84K €-9.32 Million €-23.58 Million €-9.15 Million

Herantis Pharma Oyj Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Herantis Pharma Oyj's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets €2.57 Million €6.75 Million €6.23 Million €6.92 Million €16.42 Million
Total Current Assets €2.57 Million €6.75 Million €6.23 Million €6.76 Million €13.54 Million
Cash & Equivalents €634.52K €5.50 Million €5.04 Million €6.44 Million €12.34 Million
Short-term Investments €1.50 Million €985.24K €955.05K €985.24K €985.24K
Net Receivables €406.46K €257.36K €241.29K €142.74K €174.34K
Inventory
Property, Plant & Equipment €0.00 €0.00 €0.00
Goodwill
Total Liabilities €2.81 Million €2.02 Million €6.29 Million €6.36 Million €8.83 Million
Total Current Liabilities €634.00K €1.99 Million €1.90 Million €1.89 Million €2.89 Million
Long-term Debt €2.18 Million €29.85K €4.39 Million €6.29 Million €5.94 Million
Net Debt €-605.00K €-5.47 Million €-494.69K €-939.10K €-5.13 Million
Total Stockholder Equity €-243.00K €4.73 Million €-60.28K €554.30K €7.59 Million
Retained Earnings €-80.07 Million €-75.10 Million €-75.38 Million €-66.06 Million €-54.98 Million

Herantis Pharma Oyj Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Herantis Pharma Oyj generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow €-6.54 Million €-4.64 Million €-8.94 Million €-9.93 Million €-8.56 Million
Capital Expenditures €0.00 €3.70 €0.00 €0.00 €0.00
Free Cash Flow €-6.54 Million €-4.64 Million €-8.94 Million €-9.93 Million €-8.56 Million
Investing Cash Flow €-474.00K €607.08K €-210.13K €-1.05 Million €3.69K
Financing Cash Flow €2.15 Million €4.50 Million €8.56 Million €4.03 Million €14.88 Million
Dividends Paid
Stock-Based Compensation
Depreciation €0.00 €159.71K €2.72 Million €927.71K
Change in Cash €-4.87 Million €467.24K €-594.62K €-5.90 Million €6.33 Million

Herantis Pharma Oyj Earnings History — EPS Actual vs. Analyst Estimates

Track Herantis Pharma Oyj's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Mar 04, 2026
Aug 21, 2025
Apr 24, 2025
Mar 06, 2025
Nov 09, 2024
Mar 02, 2023 -0.22
Aug 25, 2022 -0.46
Mar 07, 2022 -0.37